FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022074418> ?p ?o ?g. }

• W2022074418 endingPage "48" @default.
• W2022074418 startingPage "44" @default.
• W2022074418 abstract "Abstract Background: The elucidation of the genetic background of the myeloproliferative neoplasms completely changed the management of these disorders: the presence of the Philadelphia chromosome and/or the BCR-ABL oncogene is pathognomonic for chronic myeloid leukemia and identification of JAK2 gene mutations are useful in polycytemia vera (PV), essential thrombocytemia (ET) and myelofibrosis (PMF). The aim of this study was to investigate the role of molecular biology tests in the management of myeloproliferative neoplasms. Materials and methods: We tested the blood samples of 117 patients between April 2008 and February 2013 at the Molecular Biology of UMF Târgu Mureș using RQ-PCR (for M-BCR-ABL oncogene) and/or allele-specific PCR (for JAK 2V617F mutation). Results: Thirty-two patients presented the M-BCR-ABL oncogene, 16 of them were regularly tested as a follow-up of the administered therapy: the majority of chronic phase patients presented decreasing or stable values, while in case of accelerated phase and blast phase the M-BCR-ABL values increased or remained at the same level. Twenty patients were identified with the JAK2V617F mutation: 8 patients with PV, 4 with ET, 3 with PMF, 4 with unclassifiable chronic myeloproliferative disease and 1 patient with chronic myelomonocytic leukemia. There was no case of concomitant occurance of both molecular markers. Conclusions: Molecular biology testing plays an important role in the management of myeloproliferative neoplasms: identification of the molecular markers confirms the final diagnosis, excluding secondary causes of abnormal blood count parameters. Regular monitoring of MBCR- ABL expression level is useful in the follow-up of therapeutic efficiency." @default.
• W2022074418 created "2016-06-24" @default.
• W2022074418 creator A5019487529 @default.
• W2022074418 creator A5023633181 @default.
• W2022074418 creator A5025103654 @default.
• W2022074418 creator A5061511078 @default.
• W2022074418 creator A5063508191 @default.
• W2022074418 creator A5066055973 @default.
• W2022074418 creator A5068312635 @default.
• W2022074418 creator A5084432860 @default.
• W2022074418 date "2014-04-01" @default.
• W2022074418 modified "2023-10-17" @default.
• W2022074418 title "The Importance of Identification of M-BCRABL Oncogene and JAK2^V617F Mutation in Myeloproliferative Neoplasms" @default.
• W2022074418 cites W1532264002 @default.
• W2022074418 cites W1976756752 @default.
• W2022074418 cites W1985177017 @default.
• W2022074418 cites W1994735158 @default.
• W2022074418 cites W2002889159 @default.
• W2022074418 cites W2036862498 @default.
• W2022074418 cites W2043427864 @default.
• W2022074418 cites W2056777053 @default.
• W2022074418 cites W2083614833 @default.
• W2022074418 cites W2102960612 @default.
• W2022074418 cites W2107398329 @default.
• W2022074418 cites W2129398278 @default.
• W2022074418 cites W2136868092 @default.
• W2022074418 cites W2139704197 @default.
• W2022074418 cites W2141324982 @default.
• W2022074418 cites W2144664431 @default.
• W2022074418 cites W2166654361 @default.
• W2022074418 cites W3026191249 @default.
• W2022074418 cites W88021532 @default.
• W2022074418 cites W9782988 @default.
• W2022074418 doi "https://doi.org/10.2478/amma-2014-0010" @default.
• W2022074418 hasPublicationYear "2014" @default.
• W2022074418 type Work @default.
• W2022074418 sameAs 2022074418 @default.
• W2022074418 citedByCount "0" @default.
• W2022074418 crossrefType "journal-article" @default.
• W2022074418 hasAuthorship W2022074418A5019487529 @default.
• W2022074418 hasAuthorship W2022074418A5023633181 @default.
• W2022074418 hasAuthorship W2022074418A5025103654 @default.
• W2022074418 hasAuthorship W2022074418A5061511078 @default.
• W2022074418 hasAuthorship W2022074418A5063508191 @default.
• W2022074418 hasAuthorship W2022074418A5066055973 @default.
• W2022074418 hasAuthorship W2022074418A5068312635 @default.
• W2022074418 hasAuthorship W2022074418A5084432860 @default.
• W2022074418 hasBestOaLocation W20220744181 @default.
• W2022074418 hasConcept C104317684 @default.
• W2022074418 hasConcept C121608353 @default.
• W2022074418 hasConcept C125418893 @default.
• W2022074418 hasConcept C126322002 @default.
• W2022074418 hasConcept C138626823 @default.
• W2022074418 hasConcept C170493617 @default.
• W2022074418 hasConcept C203014093 @default.
• W2022074418 hasConcept C2776960273 @default.
• W2022074418 hasConcept C2778461978 @default.
• W2022074418 hasConcept C2778729363 @default.
• W2022074418 hasConcept C2778837598 @default.
• W2022074418 hasConcept C2778904597 @default.
• W2022074418 hasConcept C2779282312 @default.
• W2022074418 hasConcept C2780007613 @default.
• W2022074418 hasConcept C2780076729 @default.
• W2022074418 hasConcept C2781018059 @default.
• W2022074418 hasConcept C2781057849 @default.
• W2022074418 hasConcept C2781107747 @default.
• W2022074418 hasConcept C2910274570 @default.
• W2022074418 hasConcept C29537977 @default.
• W2022074418 hasConcept C42362537 @default.
• W2022074418 hasConcept C43907098 @default.
• W2022074418 hasConcept C501734568 @default.
• W2022074418 hasConcept C502942594 @default.
• W2022074418 hasConcept C54355233 @default.
• W2022074418 hasConcept C71924100 @default.
• W2022074418 hasConcept C86803240 @default.
• W2022074418 hasConceptScore W2022074418C104317684 @default.
• W2022074418 hasConceptScore W2022074418C121608353 @default.
• W2022074418 hasConceptScore W2022074418C125418893 @default.
• W2022074418 hasConceptScore W2022074418C126322002 @default.
• W2022074418 hasConceptScore W2022074418C138626823 @default.
• W2022074418 hasConceptScore W2022074418C170493617 @default.
• W2022074418 hasConceptScore W2022074418C203014093 @default.
• W2022074418 hasConceptScore W2022074418C2776960273 @default.
• W2022074418 hasConceptScore W2022074418C2778461978 @default.
• W2022074418 hasConceptScore W2022074418C2778729363 @default.
• W2022074418 hasConceptScore W2022074418C2778837598 @default.
• W2022074418 hasConceptScore W2022074418C2778904597 @default.
• W2022074418 hasConceptScore W2022074418C2779282312 @default.
• W2022074418 hasConceptScore W2022074418C2780007613 @default.
• W2022074418 hasConceptScore W2022074418C2780076729 @default.
• W2022074418 hasConceptScore W2022074418C2781018059 @default.
• W2022074418 hasConceptScore W2022074418C2781057849 @default.
• W2022074418 hasConceptScore W2022074418C2781107747 @default.
• W2022074418 hasConceptScore W2022074418C2910274570 @default.
• W2022074418 hasConceptScore W2022074418C29537977 @default.
• W2022074418 hasConceptScore W2022074418C42362537 @default.
• W2022074418 hasConceptScore W2022074418C43907098 @default.
• W2022074418 hasConceptScore W2022074418C501734568 @default.

• next